BIRM ECA 10-142
Alternative Names: C8 BIRM; ECA 10-142Latest Information Update: 20 Aug 2002
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 15 Oct 1998 Profile reviewed
- 31 Jan 1997 New profile
- 07 Aug 1994 Phase-II clinical trials for HIV infections treatment in Colombia (PO)